Is ImmunoGen Running Out of Steam, or Taking a Breather?

Is ImmunoGen Running Out of Steam, or Taking a Breather?

There's good news and bad news for ImmunoGen (NASDAQ: IMGN) shareholders. The good news is that the biotech stock is up more than 230% so far in 2017. The bad news? Shares have dropped nearly 20% in the last couple of weeks.

Certainly, ImmunoGen's tremendous performance this year outweighs its recent decline. But is ImmunoGen now running out of steam -- or is it just taking a breather?  

Image source: Getty Images.

Continue reading

Source: Fool.com